Inmune Bio, Inc. (NASDAQ:INMB) is held by 80 institutional investors per 13F filings through March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 1,194,112 | -17,988 | -1.48% | $1,349,347.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 687,015 | 687,015 | 0.00% | $776,327.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 494,969 | 53,319 | 12.07% | $559,464.00 |
| State Street Corp | 31 Mar, 2026 | 290,879 | -56,380 | -16.24% | $328,693.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 270,317 | 249,798 | 1,217.40% | $305,458.00 |
| UBS Group AG | 31 Mar, 2026 | 253,340 | 192,537 | 316.66% | $286,274.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 231,586 | 118,632 | 105.03% | $261,692.00 |
| Raymond James Financial Inc | 31 Mar, 2026 | 203,245 | -7,433 | -3.53% | $229,667.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Mar, 2026 | 194,391 | -56,519 | -22.53% | $219,662.00 |
| Northern Trust Corp | 31 Mar, 2026 | 184,225 | 8,576 | 4.88% | $208,174.00 |
| Dauntless Investment Group, LLC | 31 Mar, 2026 | 183,476 | -121,446 | -39.83% | $207,328.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 129,218 | 129,218 | 0.00% | $146,016.00 |
| VANGUARD FIDUCIARY TRUST CO | 31 Mar, 2026 | 123,184 | 123,184 | 0.00% | $139,198.00 |
| Westside Investment Management, Inc. | 31 Mar, 2026 | 108,300 | -650 | -0.60% | $122,383.00 |
| Bank of New York Mellon Corp | 31 Mar, 2026 | 53,628 | -4,893 | -8.36% | $60,599.00 |
| JANE STREET GROUP, LLC | 31 Mar, 2026 | 50,944 | 27,987 | 121.91% | $57,566.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Mar, 2026 | 50,252 | 0 | 0.00% | $56,785.00 |
| Laird Norton Wetherby Trust Company, LLC | 31 Mar, 2026 | 50,000 | 5,000 | 11.11% | $56,500.00 |
| Morgan Stanley | 31 Mar, 2026 | 44,611 | -77,901 | -63.59% | $50,411.00 |
| Focus Partners Advisor Solutions, LLC | 31 Mar, 2026 | 43,025 | 1,928 | 4.69% | $48,618.00 |